INVESTORS
Investor information
Company overview, platform focus and development stage, with a direct route to the investor contact. No financing, valuation or offering information is published on this page.
COMPANY
Preclinical genetic-medicine company, founded 2021, Columbus, Ohio
PLATFORM
Genobots: non-viral, structurally engineered DNA delivery
STAGE
Preclinical platform technology, evaluated across genetic diseases
Where to learn more
The Genobot platform: how the delivery architecture is designed and evaluated.
Pipeline: the preclinical programs and their development status.
Company: origin, focus and the people involved.
Investor inquiries
Send a note using the form below, or email investments@dnananobots.com.
Investor Portal
This page is informational only. It is not an offer to sell or a solicitation of an offer to buy any security. Statements about intended development are forward-looking and subject to change.